Cargando…
Neuroprotective Effect of S-trans, Trans-farnesylthiosalicylic Acid via Inhibition of RAS/ERK Pathway for the Treatment of Alzheimer’s Disease
BACKGROUND: Alzheimer’s disease (AD), a leading cause of dementia, becomes a serious health issue for individuals and society around the world. AD is a neurodegenerative disease characterized by the deposition of amyloid-β (Aβ) peptides and neurofibrillary tangles (NFT) and the loss of large numbers...
Autores principales: | Wang, Xiang, Wang, Yu, Zhu, Yiyi, Yan, Luxia, Zhao, Liandong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6890185/ https://www.ncbi.nlm.nih.gov/pubmed/31819374 http://dx.doi.org/10.2147/DDDT.S233283 |
Ejemplares similares
-
Farnesylthiosalicylic Acid-Loaded Albumin Nanoparticle Alleviates Renal Fibrosis by Inhibiting Ras/Raf1/p38 Signaling Pathway
por: Huang, Hui, et al.
Publicado: (2021) -
Farnesylthiosalicylic acid sensitizes hepatocarcinoma cells to artemisinin derivatives
por: Wu, Liping, et al.
Publicado: (2017) -
Farnesylthiosalicylic acid-derivatized PEI-based nanocomplex for improved tumor vaccination
por: Chen, Yuang, et al.
Publicado: (2021) -
All-trans retinoic acid inhibits the proliferation of SGC7901 cells by regulating caveolin-1 localization via the ERK/MAPK signaling pathway
por: Zhang, Sumei, et al.
Publicado: (2018) -
trans-Resveratrol as A Neuroprotectant
por: Robb, Ellen L., et al.
Publicado: (2010)